{"slug":"tb-500-postherpetic","verification":{"valid":true,"entries":2,"head":"81db4b8853871e12f8ae385b34695076d910a8f64de3618d7997a88e9118ba45"},"energy":{"passes":2,"tokens_in":12558,"tokens_out":2888,"tokens_total":15446,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"81db4b8853871e12f8ae385b34695076d910a8f64de3618d7997a88e9118ba45"},"provenance":[{"ts":"2026-06-29T23:33:00.410Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: TB 500 for Postherpetic\nSlug: tb-500-postherpetic\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"tb-500\",\"name\":\"TB-500\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"tb-500\",\"name\":\"TB-500\",\"section_title\":\"Why TB-500 might help you\",\"layer\":\"inflammation clearance / repair-cell migration\",\"steps\":[\"**What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\",\"**What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\",\"**Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\"],\"prose\":\"1. **What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\\n2. **What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\\n3. **Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stac","response":"{\n  \"slug\": \"tb-500-postherpetic\",\n  \"title\": \"TB-500 for Postherpetic Neuralgia: Evidence Review\",\n  \"body\": \"## What's breaking down\\nPostherpetic neuralgia develops after a shingles outbreak caused by the varicella-zoster virus. The virus damages sensory nerves, leaving persistent inflammation, disrupted nerve signaling, and impaired repair processes. Repair cells may fail to reach damaged axons efficiently, inflammation lingers instead of clearing, and the actin cytoskeleton in cells can become disorganized, slowing structural rebuilding. These layers keep the pain chronic rather than allowing full resolution.\\n\\n## Why TB-500 might help you\\n1. **What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\\n2. **What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\\n3. **Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\\n\\n## How these fit together\\nSingle-compound focus — TB-500 targets inflammation clearance / repair-cell migration. If your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n\\n## What the evidence actually shows\\nNo human clinical trials exist for TB-500 in postherpetic neuralgia. Preclinical animal studies in diabetic peripheral neuropathy models (mice) show thymosin beta-4 improving sciatic nerve function, motor and sensory conduction velocities, and neurovascular recovery (Wang et al., 2012, Neurobiol Dis). These are rat/mouse studies only and do not prove effects in viral nerve damage like PHN. Mechanistic data link thymosin beta-4 to actin regulation and cell migration in tissue repair models. Anecdotal reports on Reddit mention users trying TB-500 (often with BPC-157) after shingles, with some noting no added issues but no control","tokens_in":12558,"tokens_out":2888,"cost":0,"prev":"genesis","hash":"be75cf2ee3ffa48aa5fadb014d6c3416569ddec013ad43b4c04dc9d498e700e4"},{"ts":"2026-07-17T02:42:18.017Z","model":"owner","action":"voxel_divide","prompt":"","input":"tb-500-postherpetic","response":"18 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"be75cf2ee3ffa48aa5fadb014d6c3416569ddec013ad43b4c04dc9d498e700e4","hash":"81db4b8853871e12f8ae385b34695076d910a8f64de3618d7997a88e9118ba45"}]}